StockData
AC Immune SA logo

AC Immune SA (ACIU) stock

ACIUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 13, 2026Score 3/30
$2.13−0.01 (-0.47%)

Close on Nov 13, 2026Market cap $216.71MP/E –Yield –

AC Immune statistics

60 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
–

Valuation ratiosIndustry

Market Cap
CHF 177.53M
–
Enterprise Value
CHF 149.77M
–
PS Ratio
49.69
–

Enterprise valuationIndustry

EV / Sales
41.92
–

Share statisticsIndustry

Shares Change (YoY)
1.06%
10.4%
Float
78M
47M
Shares Held by Insiders
23.6%
13.5%

Short sellingIndustry

Short Interest
3M
–
Short Interest Change
-9.72%
–
Days to Cover
16.88
–

Stock price statisticsIndustry

Price Change (1 Week)
-4.48%
–
Price Change (1 Month)
-13.1%
–
Price Change (3 Months)
-15.8%
–
Price Change (6 Months)
-23.7%
–
Price Change (YTD)
-32.2%
–
Price Change (1 Year)
-35.1%
–
Price Change (3 Years)
-28.0%
–
Price Change (5 Years)
-63.9%
–
Price Change (10 Years)
-85.5%
–
Average Volume (10 Days)
235,404
–
Average Volume (20 Days)
209,449
–
Average Volume (90 Days)
201,715
–
Relative Volume
0.56
–
Relative Strength Index (14)
41.7
–
Volatility (1 Year)
66.4%
–
Beta (5 Years)
1.17
–

MarginsIndustry

Operating Margin
-1940.1%
–
Pretax Margin
-1971.7%
–
EBITDA Margin
-1940.1%
–
FCF Margin
-1963.7%
–

Returns on capitalIndustry

Return on Capital Employed (ROCE)
-138.2%
-133.0%

Financial positionIndustry

Current Ratio
0.93
2.65
Quick Ratio
0.38
2.21
Interest Coverage
-362.92
-116.78

GrowthIndustry

Revenue Growth (YoY)
-86.9%
–
FCF Growth (YoY)
-207.5%
–
Revenue Growth (3Y CAGR)
-3.17%
–
Revenue Growth (5Y CAGR)
-25.4%
–

EfficiencyIndustry

Asset Turnover
0.02
–
Revenue Per Employee
CHF 29.29K
–
Employee Count
122
49
WACC
11.0%
–

Income statement (TTM)Industry

Revenue
CHF 3.57M
–
Operating Income
-CHF 69.32M
-CHF 69.32M
Pretax Income
-CHF 70.45M
-CHF 70.45M
EBITDA
-CHF 69.32M
-CHF 69.32M
EPS (Diluted)
-0.70 CHF
-1.65 CHF

Balance sheetIndustry

Cash & Short-Term Investments
CHF 27.76M
CHF 27.76M
Net Cash (Debt)
CHF 27.76M
CHF 27.76M
Net Cash Per Share
0.27 CHF
1.03 CHF
Working Capital
-CHF 6.84M
CHF 11.40M

Cash flow (TTM)Industry

Operating Cash Flow
-CHF 69.26M
-CHF 51.26M
Capital Expenditures
-CHF 900.00K
-CHF 446.00K
Free Cash Flow
-CHF 70.16M
-CHF 51.97M
FCF Per Share
-0.69 CHF
-1.11 CHF

Dividends and yieldsIndustry

FCF Yield
-39.5%
–

Taxes and interestIndustry

Interest Expense
CHF 191.00K
CHF 833.00K
Income Tax
CHF 0
CHF 0

Scores and fair valueIndustry

Altman Z-Score
-4.82
–

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodACIUS&P 500DifferenceACIU per yearS&P 500 per year
1 month-11.3%-3.0%−8.2 pts
3 months-17.1%-2.8%−14.3 pts
Year to date-32.2%+11.5%−43.7 pts
1 year-34.1%+13.5%−47.5 pts
3 years-26.6%+77.7%−104.3 pts-9.8%+21.1%
5 years-63.9%+72.6%−136.5 pts-18.4%+11.5%
10 years-85.9%+308.2%−394.1 pts-17.8%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

3M ACIU shares were sold short on Oct 30, 2026, down 9.7% from the previous report. At recent volumes it would take 16.9 days to buy them back. Over the last 20 sessions, 50.8% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20262,947,102-9.7%174,56716.9
Oct 15, 20263,264,447-7.4%219,31714.9
Sep 30, 20263,524,624+1.4%188,11518.7
Sep 15, 20263,475,472+5.4%139,04025.0
Aug 31, 20263,296,131-3.2%219,90015.0
Aug 14, 20263,405,907-4.1%238,33614.3
Jul 31, 20263,551,322+4.6%195,35218.2
Jul 15, 20263,395,949+0.6%255,88713.3
Jun 30, 20263,376,932-4.0%260,01713.0
Jun 15, 20263,516,192+4.9%366,2189.6
May 29, 20263,353,471+3.9%205,58116.3
May 15, 20263,226,453+6.3%318,71710.1

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?